Standard operating procedures and protocols are not followed, established, or adequate.
Inspection Record
Berkshire Sterile Manufacturing — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Written records of investigations into unexplained discrepancies do not always include appropriate documentation, conclusions, and follow-up.
The facility is not adequately maintained.
Procedures designed to prevent microbial contamination of drug products purporting to be sterile are not established, written, or followed.
The program for the visual inspection (VJ) of sterile injectable drug products does not provide adequate assurance that finished products manufactured at the facility possess their purported quality attributes, including that they are free from particulate matter and critical defects.
The!” formulation process is not adequately controlled or designed to minimize the contamination risk of upstream drug product manufacturing steps.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Serum Institute of India Pvt. Ltd.2022-04-19 · US FDASimilar to finding 2 Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
- OPS International Inc dba Olympia Pharmaceuticals2026-09-03 · US FDASimilar to finding 2 Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
- MSD Ireland (Carlow)2025-04-01 · US FDASimilar to finding 2 Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
- Absolute Pharmacy LLC2016-05-18 · US FDASimilar to finding 5 Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not established, written, and followed.
- Leiter's Enterprises, Inc. dba Leiter's2018-10-24 · US FDASimilar to finding 5 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed.
A record as of the US FDA document published on 2026-10-19. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.